Correlation Between Conduit Pharmaceuticals and Amylyx Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Conduit Pharmaceuticals and Amylyx Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Conduit Pharmaceuticals and Amylyx Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Conduit Pharmaceuticals and Amylyx Pharmaceuticals, you can compare the effects of market volatilities on Conduit Pharmaceuticals and Amylyx Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Conduit Pharmaceuticals with a short position of Amylyx Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Conduit Pharmaceuticals and Amylyx Pharmaceuticals.

Diversification Opportunities for Conduit Pharmaceuticals and Amylyx Pharmaceuticals

-0.16

Correlation Coefficient

Conduit Pharmaceuticals  Amylyx Pharmaceuticals

Good diversification

The 3 months correlation between Conduit and Amylyx is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding Conduit Pharmaceuticals and Amylyx Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amylyx Pharmaceuticals and Conduit Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Conduit Pharmaceuticals are associated (or correlated) with Amylyx Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amylyx Pharmaceuticals has no effect on the direction of Conduit Pharmaceuticals i.e., Conduit Pharmaceuticals and Amylyx Pharmaceuticals go up and down completely randomly.

Pair Corralation between Conduit Pharmaceuticals and Amylyx Pharmaceuticals

Assuming the 90 days horizon Conduit Pharmaceuticals is expected to generate 3.57 times more return on investment than Amylyx Pharmaceuticals. However, Conduit Pharmaceuticals is 3.57 times more volatile than Amylyx Pharmaceuticals. It trades about 0.13 of its potential returns per unit of risk. Amylyx Pharmaceuticals is currently generating about 0.03 per unit of risk. If you would invest  0.65  in Conduit Pharmaceuticals on December 29, 2024 and sell it today you would earn a total of  0.42  from holding Conduit Pharmaceuticals or generate 64.62% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	85.25%
Values	Daily Returns

Conduit Pharmaceuticals  vs.  Amylyx Pharmaceuticals

Conduit Pharmaceuticals

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Conduit Pharmaceuticals are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Conduit Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Amylyx Pharmaceuticals

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Amylyx Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating essential indicators, Amylyx Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Conduit Pharmaceuticals and Amylyx Pharmaceuticals

The main advantage of trading using opposite Conduit Pharmaceuticals and Amylyx Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Conduit Pharmaceuticals position performs unexpectedly, Amylyx Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amylyx Pharmaceuticals will offset losses from the drop in Amylyx Pharmaceuticals' long position.

The idea behind Conduit Pharmaceuticals and Amylyx Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .